Safety and Efficacy of SA09012 in Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

November 30, 2015

Conditions
Mild to Moderate Bronchial Asthma
Interventions
DRUG

SA09012 Low dose

Tablet, b.i.d

DRUG

SA09012 High dose

Tablet, b.i.d

DRUG

Placebo

Tablet, b.i.d

Trial Locations (14)

Unknown

Chonbuk National University Hospital, Chonbuk

Chonnam National University Hospital, Gwangju

Ajou University Hospital, Gyeonggi-do

Bucheon St. Mary's Hospital, The Catholic University of Korea, Gyeonggi-do

Hallym University Sacred Heart Hospital, Gyeonggi-do

Soon Chun Hyang University Bucheon Hospital, Gyeonggi-do

Chungbuk National University Hospital, Jungbuk

Konkuk University Medical Center, Seoul

Korea University Guro Hospital, Seoul

KyungHee University Medical Center, Seoul

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul

Soonchunhyang University Hospital, Seoul, Seoul

St. Paul's Hospital, The Catholic University of Korea, Seoul

Yonsei University, Gangnam Severance Hospital, Seoul

All Listed Sponsors
lead

SamA Pharmaceutical Co., Ltd

INDUSTRY

NCT01740986 - Safety and Efficacy of SA09012 in Asthma | Biotech Hunter | Biotech Hunter